Predict your next investment

HEALTHCARE | Biotechnology
adagiotx.com

See what CB Insights has to offer

Total Raised

$466M

Investors Count

16

Deal Terms

1

Adagio Therapeutics Funding, Adagio Therapeutics Valuation & Adagio Therapeutics Revenue

5 Fundings

Adagio Therapeutics's latest funding round was a IPO for $309.4M on August 6, 2021.

Adagio Therapeutics's latest post-money valuation is from August 2021.

Sign up for a free 30-day trial to see Adagio Therapeutics's valuations in August 2021 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

8/6/2021

IPO

$309.4M

$99M

$0.00B

((9.99x))

FY 1234

1

4/19/2021

Series C

$99M

$0.00B

((9.99x))

FY 1234

10

11/10/2020

Series B

$99M

$0.00B

((9.99x))

FY 1234

10

7/16/2020

Series A

$99M

$0.00B

((9.99x))

FY 1234

10

1/1/2020

Spinoff / Spinout

$99M

$0.00B

((9.99x))

FY 1234

10

Date

8/6/2021

4/19/2021

11/10/2020

7/16/2020

1/1/2020

Round

IPO

Series C

Series B

Series A

Spinoff / Spinout

Amount

$309.4M

$99M

$99M

$99M

$99M

Investors

Valuation

$99M

Revenue

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

Sources

1

10

10

10

10

Adagio Therapeutics Deal Terms

1 Deal Term

Adagio Therapeutics's deal structure is available for 1 funding round, including their IPO from August 06, 2021.

Round

IPO

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

IPO

Adagio Therapeutics Investors

16 Investors

Adagio Therapeutics has 16 investors. Fidelity Investments invested in Adagio Therapeutics's Series C funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

7/16/2020

4/19/2021

3
Series A, Series B (2020), Series C (2021)

Diversified Financial Services

Massachusetts

7/16/2020

4/19/2021

3
Series A, Series B (2020), Series C (2021)

Corporate Venture

California

7/16/2020

4/19/2021

3
Series A, Series B (2020), Series C (2021)

Venture Capital

New York

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Venture Capital

Massachusetts

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Venture Capital

Texas

First funding

7/16/2020

7/16/2020

7/16/2020

00/00/0000

00/00/0000

Last Funding

4/19/2021

4/19/2021

4/19/2021

00/00/0000

00/00/0000

Investor

Subscribe to see more

Subscribe to see more

Rounds

3
Series A, Series B (2020), Series C (2021)
3
Series A, Series B (2020), Series C (2021)
3
Series A, Series B (2020), Series C (2021)

Subscribe to see more

Subscribe to see more

Board Seats

Subscribe to see more

Subscribe to see more

Type

Diversified Financial Services

Corporate Venture

Venture Capital

Venture Capital

Venture Capital

Location

Massachusetts

California

New York

Massachusetts

Texas

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.